Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation

Journal of the American Society of Nephrology

Volumn 21, Issue 9, 2010, Pages 1579-1586

  Smith, Jodi M ^a   Corey, Lawrence ^b   Bittner, Rachel ^b   Finn, Laura S ^b   Healey, Patrick J ^a   Davis, Connie L ^a   McDonald, Ruth A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS INFECTION; FEMALE; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIREMIA; VIRUS LOAD; ALLOTRANSPLANTATION; CHRONIC DISEASE; COMPLICATION; FIBROSIS; INCIDENCE; KIDNEY; PATHOLOGY; PRESCHOOL CHILD; PROSPECTIVE STUDY; RISK; STATISTICAL MODEL;

ANTIVIRUS AGENT;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FIBROSIS; HUMANS; INCIDENCE; KIDNEY; KIDNEY TRANSPLANTATION; LINEAR MODELS; MALE; PROSPECTIVE STUDIES; RISK; TRANSPLANTATION, HOMOLOGOUS; VIREMIA;

EID: 77956546382     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009111188     Document Type: Article

References (33)

1. Husain S, Singh N: The impact of novel immunosuppressive agents on infections in organ transplant recipients and the interactions of these agents with antimicrobials. Clin Infect Dis 35: 53-61, 2002
2. Dharnidharka VR, Stablein DM, Harmon WE: Post-transplant infections now exceed acute rejection as cause for hospitalization: A report of the NAPRTCS. Am J Transplant 4: 384-389, 2004
3. Humar A, Gillingham KJ, Payne WD, Dunn DL, Sutherland DE, Matas AJ: Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients. Transplantation 68: 1879-1883, 1999
4. Rubin RH, Tolkoff-Rubin NE, Oliver D, Rota TR, Hamilton J, Betts RF, Pass RF, Hillis W, Szmuness W, Farrell ML: Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation 40: 243-249, 1985 (Pubitemid 15023180)
5. Soderberg-Naucler C, Emery VC: Viral infections and their impact on chronic renal allograft dysfunction. Transplantation 71[Suppl]: SS24-SS30, 2001
6. Tong CY, Bakran A, Peiris JS, Muir P, Herrington CS: The association of viral infection and chronic allograft nephropathy with graft dysfunction after renal transplantation. Transplantation 74: 576-578, 2002 (Pubitemid 34977693)
7. Borchers AT, Perez R, Kaysen G, Ansari AA, Gershwin ME: Role of cytomegalovirus infection in allograft rejection: A review of possible mechanisms. Transpl Immunol 7: 75-82, 1999 (Pubitemid 29472068)
8. Koskinen PK, Kallio EA, Tikkanen JM, Sihvola RK, Häyry PJ, Lemström KB: Cytomegalovirus infection and cardiac allograft vasculopathy. Transpl Infect Dis 1: 115-126, 1999
9. Lautenschlager I, Soots A, Krogerus L, Kauppinen H, Saarinen O, Bruggeman C, Ahonen J: Effect of cytomegalovirus on an experimental model of chronic renal allograft rejection under triple-drug treatment in the rat. Transplantation 64: 391-398, 1997 (Pubitemid 27349875)
10. Streblow DN, Kreklywich C, Yin Q, De La Melena VT, Corless CL, Smith PA, Brakebill C, Cook JW, Vink C, Bruggeman CA, Nelson JA, Orloff SL: Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants. J Virol 77: 2182-2194, 2003 (Pubitemid 36110031)
11. Lemström KB, Koskinen PK, Bruning JH, Bruggeman CA, Lautenschlager IT, Häyry PJ: Effect of ganciclovir prophylaxis on cytomegalovirus-enhanced allograft arteriosclerosis. Transpl Int 7[Suppl 1]: S383-S384, 1994
12. Tikkanen JM, Kallio EA, Bruggeman CA, Koskinen PK, Lemström KB: Prevention of cytomegalovirus infection-enhanced experimental obliterative bronchiolitis by antiviral prophylaxis or immunosuppression in rat tracheal allografts. Am J Respir Crit Care Med 164: 672-679, 2001
13. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, Cosio F, David DS, Drachenberg C, Einecke G, Fogo AB, Gibson IW, Glotz D, Iskandar SS, Kraus E, Lerut E, Mannon RB, Mihatsch M, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Roberts I, Seron D, Smith RN, Valente M: Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 8: 753-760, 2008 (Pubitemid 351347767)
14. Kranz B, Vester U, Wingen AM, Nadalin S, Paul A, Broelsch CE, Hoyer PF: Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection. Pediatr Transplant 12: 474-478, 2008 (Pubitemid 351652068)
15. Li L, Chaudhuri A, Weintraub LA, Hsieh F, Shah S, Alexander S, Salvatierra O Jr, Sarwal MM: Subclinical cytomegalovirus and Epstein-Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation. Pediatr Transplant 11: 187-195, 2007 (Pubitemid 46174991)
16. Potena L, Holweg CT, Chin C, Luikart H, Weisshaar D, Narasimhan B, Fearon WF, Lewis DB, Cooke JP, Mocarski ES, Valantine HA: Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection. Transplantation 82: 398-405, 2006
17. Ruttmann E, Geltner C, Bucher B, Ulmer H, Höfer D, Hangler HB, Semsroth S, Margreiter R, Laufer G, Müller LC: Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation. Transplantation 81: 1415-1420, 2006 (Pubitemid 43847152)
18. Westall GP, Michaelides A, Williams TJ, Snell GI, Kotsimbos TC: Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation. Transplantation 75: 2064-2068, 2003 (Pubitemid 36793294)
19. Sagedal S, Hartmann A, Nordal KP, Osnes K, Leivestad T, Foss A, Degré M, Fauchald P, Rollag H: Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int 66: 329-337, 2004 (Pubitemid 38870110)
20. Sagedal S, Nordal KP, Hartmann A, Sund S, Scott H, Degré M, Foss A, Leivestad T, Osnes K, Fauchald P, Rollag H: The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant 2: 850-856, 2002
21. Cockfield SM, Preiksaitis JK, Jewell LD, Parfrey NA: Post-transplant lymphoproliferative disorder in renal allograft recipients: Clinical experience and risk factor analysis in a single center. Transplantation 56: 88-96, 1993
22. McDonald RA, Smith JM, Ho M, Lindblad R, Ikle D, Grimm P, Wyatt R, Arar M, Liereman D, Bridges N, Harmon W: CCTPT Study Group: Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. Am J Transplant 8: 984-989, 2008 (Pubitemid 351537758)
23. Newell KA, Alonso EM, Whitington PF, Bruce DS, Millis JM, Piper JB, Woodle ES, Kelly SM, Koeppen H, Hart J, Rubin CM, Thistlethwaite JR Jr: Posttransplant lymphoproliferative disease in pediatric liver transplantation: Interplay Between Epstein-Barr virus infection and immunosuppression. Transplantation 62: 370-375, 1996
24. Smith JM, Corey L, Healey PJ, Davis CL, McDonald RA: Primary EBV infection in pediatric renal transplantation: Adolescents at higher risk for PTLD. Transplantation 83: 1423-1428, 2007
25. Reinke P, Prösch S, Kern F, Volk HD: Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients. Transpl Infect Dis 1: 157-164, 1999
26. Wu TC, Hruban RH, Ambinder RF, Pizzorno M, Cameron DE, Baumgartner WA, Reitz BA, Hayward GS, Hutchins GM: Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts. Am J Pathol 140: 739-747, 1992
27. Gerstenkorn C, Robertson H, Mohamed MA, O'Donnell M, Ali S, Talbot D: Detection of cytomegalovirus (CMV) antigens in kidney biopsies and transplant nephrectomies as a marker for renal graft dysfunction. Clin Chem Lab Med 38: 1201-1203, 2000 (Pubitemid 32007781)
28. Barzon L, Murer L, Pacenti M, Biasolo MA, Della Vella M, Benetti E, Zanon GF, Palú G: Investigation of intrarenal viral infections in kidney transplant recipients unveils an association between parvovirus B19 and chronic allograft injury. J Infect Dis 199: 372-380, 2009
29. Lai KK, Cook L, Krantz EM, Corey L, Jerome KR: Calibration curves for real-time PCR. Clin Chem 51: 1132-1136, 2005
30. Boeckh M, Huang M, Ferrenberg J, Stevens-Ayers T, Stensland L, Nichols WG, Corey L: Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR. J Clin Microbiol 42: 1142-1148, 2004 (Pubitemid 38332838)
31. Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S, Matsuyama T, Morishima T: Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 37: 132-136, 1999 (Pubitemid 29004193)
32. Humar A, Michaels M: American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 6: 262-274, 2006 (Pubitemid 43382161)
33. Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL: New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20: 629-637, 2009